Literature DB >> 262180

Liquid chromatographic analysis of disopyramide and its mono-N-dealkylated metabolite.

J J Lima.   

Abstract

We describe a rapid, sensitive, and specific "high performance" liquid chromatographic analysis for disopyramide and its mono-N-dealkylated metabolite in serum, urine, and saliva. We used a mu-Bondapak CN column and an acetate buffer mobile phase containing methanol. Retention times for the two compounds and the internal standard, p-chlorodisopyramide, were 3.4, 4.1, and 6.3 min, respectively. The lower limits of sensitivity for drug and metabolite were 50 and 80 micrograms/L, respectively, with maximum coefficients of variation of 4.6 and 12%, respectively. Currently used antiarrhythmic drugs did not interfere with the analysis of disopyramide, and the pharmacokinetics of the drug, obtained from studies of one subject, agree well with reported values.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 262180

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

Review 1.  Clinical pharmacokinetics of disopyramide.

Authors:  A Karim; C Nissen; D L Azarnoff
Journal:  J Pharmacokinet Biopharm       Date:  1982-10

2.  Disopyramide pharmacokinetics and bioavailability following the simultaneous administration of disopyramide and 14C-disopyramide.

Authors:  J J Lima; D B Haughey; C V Leier
Journal:  J Pharmacokinet Biopharm       Date:  1984-06

3.  Disopyramide and its N-monodesalkyl metabolite in breast milk.

Authors:  D B Barnett; S A Hudson; A McBurney
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

4.  Atenolol inhibits the elimination of disopyramide.

Authors:  J Bonde; S Bødtker; H R Angelo; T L Svendsen; J P Kampmann
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.